University of Colorado (CU)’s Anschutz Medical Campus closed a $50m healthcare-oriented fund yesterday that was backed by its hospital system, UCHealth, and fellow healthcare provider Children’s Hospital Colorado.
CU Healthcare Innovation Fund’s other limited partners include University of Colorado along with its medical school, CU Medicine. It will invest in early-stage healthcare startups with a link to at least one of its partners, with a focus on digital health, healthcare IT, drug development and medical devices.
The vehicle has built a portfolio of eight companies including remote patient monitoring platform BioIntelliSense, prescription decision support system developer RxRevu and clinical trial digitisation service ClinOne.
The fund has also backed specialty telemedicine provider EConsults, medical education platform Amplifire, drug manufacturing facility operator Staq Pharma, immunotherapy platform developer Complement Therapeutics and personalised drug developer Autoimmune Therapeutics.
The original version of this article appeared on our sister site, Global University Venturing.